Your session is about to expire
← Back to Search
Mindfulness-Based Attention Training for Teams (MBAT-T) for Cognitive Impairment
N/A
Waitlist Available
Led By Amishi P Jha, PhD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (testing session 1) to week 5 (testing session 2)
Awards & highlights
Study Summary
This trial will study how a mindfulness course may help people think, feel, and act differently.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (testing session 1) to week 5 (testing session 2)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (testing session 1) to week 5 (testing session 2)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Attentional Performance
Change in Working Memory Performance
Secondary outcome measures
Change in Cohesion
Change in Decentering
Change in Mindfulness
+7 moreOther outcome measures
Change in Accuracy on Cognitive and Marksmanship Drills
Change in Reaction Time on Cognitive and Marksmanship Drills
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness-Based Attention Training for Teams (MBAT-T)Experimental Treatment1 Intervention
Teams randomized to this group will receive 4, 2-2.5-hour sessions delivered over 4 weeks of mindfulness training and 15 minutes of daily, out-of-class mindfulness exercises, that will be delivered and tracked using a measuring mindfulness application.
Group II: Mindfulness-Based Attention Training for Individuals (MBAT-I)Active Control1 Intervention
Individuals randomized to this group will receive 4, 2-2.5-hour sessions delivered over 4 weeks of mindfulness training and 15 minutes of daily, out-of-class mindfulness exercises, that will be delivered and tracked using a measuring mindfulness application.
Group III: No-trainingActive Control1 Intervention
Teams will not engage in any mindfulness training
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MBAT-T
2021
N/A
~360
Find a Location
Who is running the clinical trial?
University of MiamiLead Sponsor
902 Previous Clinical Trials
409,660 Total Patients Enrolled
United States Department of DefenseFED
865 Previous Clinical Trials
327,343 Total Patients Enrolled
Amishi P Jha, PhDPrincipal InvestigatorUniversity of Miami
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger